Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+5.63%
+3.80%
-0.37%
-1.77%
+5.48%
HIMS
Hims & Hers Health I
$64.00
Chart
31.22
68.74
25.2
19.58
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.63%
+3.80%
-0.37%
-1.77%
+5.48%
HIMS
Hims & Hers Health I
$64.00
Chart
31.22
68.74
25.2
19.58
HIMS Latest Headlines
Hims & Hers Health Stock: A Rare High-Growth Value Play In Plain Sight.
Mon May 12, 2025
Hims & Hers: Still Undervalued For These 2 Reasons.
Mon May 12, 2025
Why Hims & Hers Health Inc. (HIMS) Skyrocketed This Week.
Sat May 10, 2025
Massive Hims & Hers News: $1 Billion on AI and Acquisitions. Hims &. Hers (NYSE: HIMS) stock has been on fire in 2025 and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims &. Hers should move overseas and artificial intelligence will play a bigger ro
Sat May 10, 2025
Hims & Hers Stocks 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started. If short sellers were hoping for a flop from ) they may want to check their risk management settings. The telehealth disruptor dropped first-quarter earnings after the bell on Monday and instead of the crash shorts were counting on the market got a ish cocktail: strong guidance solid revenue growth and a headline-making partnership with Novo Nordisk A/S (NYSE:).Shares popped &. and they’.ve kept climbing
Thu May 8, 2025
Hims & Hers Health Stock Is Sliding Thursday: Whats Going On?. ) shares are falling Thursday morning after the company announced a proposed convertible senior notes offering.Hims &. Hers Health intends to use the proceeds to help accelerate global expansion through organic growth and strategic acquisitions as well as for general corporate purposes. The proceeds will also help support the company’.s technology team to expand its data pipeline develop AI tools and advance personalized trea
Thu May 8, 2025
Hims & Hers names former president and CTO at Cruise as Chief Technology Officer.
Thu May 8, 2025
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations.
Thu May 8, 2025
Hims & Hers shares fall on convertible notes offering.
Thu May 8, 2025
Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade).
Wed May 7, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HIMS Stock trends
HIMS Stock performance
HIMS Stock analysis
HIMS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Don't Be a Sheep, Be a StocksRunner
StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score
Sign up for free and
continue analysing HIMS
Already a Member? Click here to Login
Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.
Don't Be a Sheep, Be a StocksRunner
StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score
Sign up for free and
continue analysing HIMS
Already a Member? Click here to Login
Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.
Login to display Hims & Hers Health I (HIMS) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
